Additional Seasonique Data Not Required To Support Extended-Cycle Approval, Barr Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The firm anticipates approval of the 91-day cycle contraceptive in "a couple months."
You may also be interested in...
Barr To Focus On Seasonique After Dropping Lo Seasonale
Company withdraws its application for the low-dose extended cycle contraceptive in advance of the user fee date.
Barr To Focus On Seasonique After Dropping Lo Seasonale
Company withdraws its application for the low-dose extended cycle contraceptive in advance of the user fee date.
Barr's Seasonique Is "Approvable" Pending Data On The Contraceptive's Regimen
The firm is seeking a meeting with FDA to discuss use of results from ongoing studies of the extended-regimen oral contraceptive.